ArticleClinical cancer research : an official journal of the American Association for Cancer Research2024

CDK9 Inhibition by Dinaciclib Is a Therapeutic Vulnerability in Epithelioid Hemangioendothelioma.

Ajaybabu V Pobbati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.